In Ovo: Funding, Investors & Team (Sep 2026)
The company In Ovo aims to improve animal welfare and efficiency in the poultry industry by offering biotechnological solutions. They specifically address a longstanding issue in hatcheries: the culling of male chickens at one day old. Their solution involves implementing a gender screening process early on in the breeding process. This approach offers several benefits such as reducing the stress experienced by the chickens during manual gender sorting, decreasing energy consumption and CO2 emissions in the hatchery, and avoiding the need to euthanize newborn chickens. In this way, In Ovo enhances the animal-friendliness and sustainability of hatcheries while also improving their overall efficiency.
In Ovo has raised $80.2M across 2 funding rounds on record, the most recent an undisclosed round of $42.4M announced in Nov 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
In Ovo Company Profile and Key Stats
Latest funding round on record: Nov 2023.
In Ovo Funding Rounds
In Ovo raised $37.8M in a Series B announced in Mar 2022.
1.7 years later, an undisclosed round of $42.4M was announced in Nov 2023.
In Ovo Founders and Leadership Team
Contact details for the In Ovo team: 1 of 1 has an email address on file.
Start 14-day free trial →In Ovo Funding Compared to Other Biotechnology Startups
In Ovo's latest round of $42.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like In Ovo in Biotechnology and Leiden
Companies Similar to In Ovo
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
In Ovo Funding FAQs
What does In Ovo do?
The company In Ovo aims to improve animal welfare and efficiency in the poultry industry by offering biotechnological solutions. They specifically address a longstanding issue in hatcheries: the culling of male chickens at one day old. Their solution involves implementing a gender screening process early on in the breeding process. This approach offers several benefits such as reducing the stress experienced by the chickens during manual gender sorting, decreasing energy consumption and CO2 emissions in the hatchery, and avoiding the need to euthanize newborn chickens. In this way, In Ovo enhances the animal-friendliness and sustainability of hatcheries while also improving their overall efficiency.
How much funding has In Ovo raised?
In Ovo has raised $80.2M across 2 rounds on record. The most recent is an undisclosed round of $42.4M announced in Nov 2023.
When did In Ovo last raise funding?
In Ovo's most recent funding round on record is an undisclosed round of $42.4M, announced in Nov 2023.
Who founded In Ovo?
FundedIQ lists Wil Stutterheim (Founder) at In Ovo.
Where is In Ovo headquartered?
In Ovo is based in Leiden, Zuid-Holland, Netherlands.
How many employees does In Ovo have?
In Ovo is in the 11-50 employee band.
How does In Ovo's funding compare to other Biotechnology startups?
In Ovo's latest round of $42.4M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's In Ovo Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for In Ovo is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.